Skip to content

Drug interactions

Elagolix + Isoniazid

Severity: Moderate

Elagolix and Isoniazid: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a CYP3A substrate, and strong CYP3A inhibitors raise its exposure, increasing the risk of bone mineral density loss and other dose-related effects. Isoniazid is only a weak-to-moderate CYP3A inhibitor, so the increase is probably modest. The risk is greatest with longer durations of therapy.

What this interaction means in plain words

Elagolix and Isoniazid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elagolix belongs to Musculoskeletal; Isoniazid belongs to Anti Bacterial.

Evidence level: Low

Why it happens

Isoniazid inhibits CYP3A4, reducing the first-pass and systemic metabolism of elagolix.

What to do

Limit the duration of concurrent use, and follow the elagolix labeling for limits on dose and duration with CYP3A inhibitors. Monitor for hypoestrogenic adverse effects such as bone loss and hot flushes.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Isoniazid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Isoniazid?

MediHelp rates the interaction as moderate. Elagolix and Isoniazid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elagolix is a CYP3A substrate, and strong CYP3A inhibitors raise its exposure, increasing the risk of bone mineral density loss and other dose-related effects. Isoniazid is only a weak-to-moderate CYP3A inhibitor, so the increase is probably modest. The risk is greatest with longer durations of therapy.

How serious is the interaction between Elagolix and Isoniazid?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit the duration of concurrent use, and follow the elagolix labeling for limits on dose and duration with CYP3A inhibitors. Monitor for hypoestrogenic adverse effects such as bone loss and hot flushes.

What other medicines interact with Isoniazid?

MediHelp also lists interactions of Isoniazid with, for example, Bacillus calmette-guerin substrain tice, Benzhydrocodone / acetaminophen, Carbamazepine. The full list is on the Isoniazid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in